Andina Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Sell
386
-70
-15% -$71.5K 0.75% 36
2026
Q1
$419K Buy
456
+191
+72% +$194K 0.37% 60
2025
Q4
$285K Sell
265
-42
-14% -$40.2K 0.17% 121
2025
Q3
$234K Sell
307
-56
-15% -$41.7K 0.13% 129
2025
Q2
$283K Buy
363
+11
+3% +$8.55K 0.2% 112
2025
Q1
$291K Buy
+352
New +$293K 0.21% 106

Other funds holding LLY

Andina Capital Management's LLY Position: Q2 2026 in Review

Andina Capital Management reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $71.5K and leaving 386 shares worth $463K. The position accounts for 0.75% of the portfolio, ranked #36.

Andina Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Andina Capital Management held 386 shares of Eli Lilly worth $463K as of Q2 2026.
  • Andina Capital Management sold 70 Eli Lilly shares in Q2 2026, an estimated $71.5K.
  • Eli Lilly made up 0.75% of Andina Capital Management's portfolio in Q2 2026, its #36 holding.
  • Andina Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Andina Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.